ARTICLE | Company News
Bristol-Myers sales and marketing update
November 2, 2015 8:00 AM UTC
Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier assessment that Nulojix belatacept from Bristol-Myers Squibb has “considerable added benefit” in preventing kid...